Asthma

To assess the quality of life of patients with asthma using AQLQ(S) and the prescription pattern of asthma drugs for the patients getting admitted to hospital. Data were collected from the patients who are eligible and analyzed thoroughly. The study population consisting of 51 excluding 10 dropouts were predominantly male (60.7%), with major trigger was found to be dust (33.33 %), other predisposing factors like BMI, occupational status, social status were also studied. 51. 56% of study population belongs to  Adult (35-51 years) who were suffering and the average age was  51.56 ±15.95 years. Outcomes measured include PEF, FEV1% the clinical outcome and the humanistic outcome QoL were also measured at two different intervals using AQLQ(S) questionnaire. The questionnaire scores revealed that patients had a positive result on all the four domains which were statistically significant (p value of ≤ 0.05). The overall score had shown an increase from 3.79 ± 0.731 to 4.96 ± 1.07, which indicates the effectiveness of treatment. There was also an improvement in activity, emotion and environmental domains. The commonly prescribed anti asthmatic drug for subjects were Salmetrol in combination with Fluticasone propionate as inhalers. Reliever medications like Salbutamol and Levosalbutamol were also prescribed widely. There were 106 drug interactions including azithromycin along with moxifloxacin and levofloxacin along with the methyl prednisolone. The above results revealed that along with the pharmacotherapy it is always better to assess the treatment provided through assessing the QoL which may confirm the effectiveness of the treatment provided

Asthma creates a substantial burden on individuals and families as it is more often under-diagnosed and under-treated. India has an estimated 15-20 million asthmatics. Recognizing the signs and symptoms of asthma is important so that treatment and other interventions can begin early. Prospective observational study was conducted in the department of general medicine, RIMS, Kadapa for the period of 6 months aimed to assess the prevalence, risk factors and treatment in asthmatic patients. Patients were enrolled into the study on the basis of inclusion and exclusion criteria. A total of 122 asthma diagnosed patients were recruited under the inclusion criteria. Our study establishes that the prevalence of bronchial asthma was more in males 79 (64.75%) than in females 43 (35.25 %). The prevalence rate of our study was 20.71 %. Our study found that most patients (35.25%) are using multiple drug therapy, followed by triple combination therapy (33.61%). Our study concluded that the asthma has low incidence and prevalence rate among the total respiratory diseases patients admitted in the hospital with the most predominant risk factors as dust, smoke and climate variation. Most patients have used multiple drug therapy for treatment due to severity of disease.